451 related articles for article (PubMed ID: 33603168)
1. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
Lin CC; Yang WH; Lin YT; Tang X; Chen PH; Ding CC; Qu DC; Alvarez JV; Chi JT
Oncogene; 2021 Mar; 40(11):2018-2034. PubMed ID: 33603168
[TBL] [Abstract][Full Text] [Related]
2. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma.
Yang WH; Ding CC; Sun T; Rupprecht G; Lin CC; Hsu D; Chi JT
Cell Rep; 2019 Sep; 28(10):2501-2508.e4. PubMed ID: 31484063
[TBL] [Abstract][Full Text] [Related]
3. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
4. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
[TBL] [Abstract][Full Text] [Related]
5. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
8. Discoidin Domain Receptor 2 Regulates AT1R Expression in Angiotensin II-Stimulated Cardiac Fibroblasts via Fibronectin-Dependent Integrin-β1 Signaling.
Titus AS; Venugopal H; Ushakumary MG; Wang M; Cowling RT; Lakatta EG; Kailasam S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502259
[TBL] [Abstract][Full Text] [Related]
9. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.
Zhang K; Corsa CA; Ponik SM; Prior JL; Piwnica-Worms D; Eliceiri KW; Keely PJ; Longmore GD
Nat Cell Biol; 2013 Jun; 15(6):677-87. PubMed ID: 23644467
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis.
Barcus CE; Hwang PY; Morikis V; Brenot A; Pence P; Clarke M; Longmore GD
J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34477203
[TBL] [Abstract][Full Text] [Related]
11. Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway.
Wang Y; Liu J; Ying X; Lin PC; Zhou BP
Sci Rep; 2016 Apr; 6():24606. PubMed ID: 27094683
[TBL] [Abstract][Full Text] [Related]
12. The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2.
Yang WH; Lin CC; Wu J; Chao PY; Chen K; Chen PH; Chi JT
Mol Cancer Res; 2021 Jun; 19(6):1005-1014. PubMed ID: 33707306
[TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.
Majkowska I; Shitomi Y; Ito N; Gray NS; Itoh Y
J Biol Chem; 2017 Apr; 292(16):6633-6643. PubMed ID: 28270508
[TBL] [Abstract][Full Text] [Related]
14. CPEB1 enhances erastin-induced ferroptosis in gastric cancer cells by suppressing twist1 expression.
Wang J; Wang T; Zhang Y; Liu J; Song J; Han Y; Wang L; Yang S; Zhu L; Geng R; Li W; Yu X
IUBMB Life; 2021 Sep; 73(9):1180-1190. PubMed ID: 34184391
[TBL] [Abstract][Full Text] [Related]
15. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1.
Mitchell AV; Wu J; Meng F; Dong L; Block CJ; Song WM; Zhang B; Li J; Wu G
Cancer Res Commun; 2022 Nov; 2(11):1388-1403. PubMed ID: 36713812
[TBL] [Abstract][Full Text] [Related]
16. Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.
Jia S; Agarwal M; Yang J; Horowitz JC; White ES; Kim KK
Am J Respir Cell Mol Biol; 2018 Sep; 59(3):295-305. PubMed ID: 29652518
[TBL] [Abstract][Full Text] [Related]
17. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
Grither WR; Longmore GD
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7786-E7794. PubMed ID: 30061414
[TBL] [Abstract][Full Text] [Related]
19. RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.
Lin CC; Mabe NW; Lin YT; Yang WH; Tang X; Hong L; Sun T; Force J; Marks JR; Yao TP; Alvarez JV; Chi JT
Cell Death Differ; 2020 Jul; 27(7):2234-2247. PubMed ID: 31988496
[TBL] [Abstract][Full Text] [Related]
20. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis.
Gao R; Kalathur RKR; Coto-Llerena M; Ercan C; Buechel D; Shuang S; Piscuoglio S; Dill MT; Camargo FD; Christofori G; Tang F
EMBO Mol Med; 2021 Dec; 13(12):e14351. PubMed ID: 34664408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
